bioRxiv · 10.64898/2026.07.30.741615
Non-canonical Oncostatin M Signaling Provides Protection during Respiratory Viral and Bacterial infections
Abstract
Pneumonia remains a major global health burden, highlighting the need for host-directed therapies to complement antimicrobial treatment. Here, we identify Oncostatin M (OSM) as a critical regulator of pulmonary host responses during influenza and bacterial pneumonia. Loss of OSM shifted lung macrophages toward a pro-inflammatory phenotype during influenza infection and exacerbated lung injury during bacterial pneumonia, demonstrating an essential role for OSM in limiting immunopathology. Unexpectedly, OSM induced Signal Transducer and Activator of Transcription 3 (STAT3) activation in the absence of the canonical OSM receptor subunit OSMr{beta}, revealing previously unrecognized non-canonical OSM signaling in the mouse lungs. Consistent with this finding, loss of OSMr{beta} did not phenocopy the severe disease observed with loss of OSM. Together, these findings identify OSM as a key regulator of pulmonary immunity and reveal unexpected complexity in OSM signaling during pneumonia.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lee, Y., Patneaude, L. J., Martins, K. R., Pihl, R. M. F., Dimbo, E. L., Perez-Vazquez, M., Jayaraman, A., Crossey, E., Armstrong, E. M. R., Hiller, B. E., Garza, I., Bosmann, M., Jones, M. R., Mizgerd, J. P., Quinton, L. J., Traber, K. E.. 2026-08-04. Non-canonical Oncostatin M Signaling Provides Protection during Respiratory Viral and Bacterial infections. https://doi.org/10.64898/2026.07.30.741615
Cite the original work for its findings. Save a collection to share your selection of sources.